Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 473 - Heterocyclic compounds containing purine ring systems
Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
05/2010
05/20/2010CA2743019A1 Akt and p70 s6 kinase inhibitors
05/20/2010CA2742833A1 Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors
05/19/2010EP2185539A1 Viral polymerase inhibitors
05/19/2010CN101229168B Immunity excitant containing selenium
05/19/2010CN101003550B 8- halogenated adenine nucleotide compound , synthetic method, medical application
05/18/2010CA2422371C Pyrazole compounds useful as protein kinase inhibitors
05/18/2010CA2422367C Pyrazole compounds useful as protein kinase inhibitors
05/14/2010WO2010054032A2 Apparatus and method using rotary flow distribution mechanisms
05/14/2010WO2010026603A3 Novel amine salts of tenofovir, process for producing the same and use thereof in production of tenofovir dioproxil
05/14/2010CA2742744A1 Apparatus and method using rotary flow distribution mechanisms
05/13/2010US20100120799 Purine derivatives as immunomodulators
05/13/2010US20100120798 Substituted piperidines containing a heteroarylamide or heteroarylphenyl moiety
05/13/2010US20100120797 Purinyl derivatives and their use as potassium channel modulators
05/13/2010US20100120765 Pyrazolyl substituted xanthines
05/13/2010US20100120754 Identification and use of small molecules to modulate transcription factor function and to treat transcription factor associated diseases
05/13/2010US20100120722 Heterocyclic compounds for preventing and treating disorders associated with excessive bone loss
05/12/2010EP2184286A1 Process for the manufacture of acyclovir pro-drugs
05/12/2010DE112008001507T5 Neue Hybridverbindungen von Nukleobasen und organischen Redox-Molekülen und ihre Verwendung New hybrid compounds of nucleobases and organic redox molecules and their use
05/12/2010CN1867336B 1-aryl-4-substituted piperazines derivatives and pharmaceutical use thereof
05/12/2010CN101704818A Method for extracting caffeine from methylated mother through adsorption separation
05/12/2010CN101016299B Process for preparing purine derivatives
05/11/2010US7713982 8-chloro-3-pentyl-3,7-dihydro-1H-purine-2,6-dione: hyperlipoproteinaemia, dyslipidaemia, heart failure, hypercholesteraemia, atherosclerosis, arteriosclerosis, and hypertriglyceridaemia
05/11/2010CA2422299C Triazole compounds useful as protein kinase inhibitors
05/11/2010CA2326324C Nitrogen-containing heterocyclic compound
05/06/2010WO2010027746A3 Hedgehog pathway modulators
05/06/2010US20100113762 Apparatus and Method Using Rotary Flow Distribution Mechanisms
05/06/2010US20100112090 Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes
05/05/2010CN1907987B Entecavir acid addition salt, preparation method and use thereof
05/05/2010CN101701027A Catalytic cracking method of nucleoside compound
05/05/2010CN101701026A Catalytic cracking method for guanosine
05/04/2010US7709637 5-phenylpyrimidines, their preparation, intermediates for their preparation, and their use for controlling harmful fungi
05/04/2010US7709486 antiviral compounds 1,4,8,11-tetraazacyclotetradecane derivatives for against HIV-infected cells, to inhibit the binding by the natural ligand to its chemokine receptor; viricides
04/2010
04/29/2010WO2010003475A3 Novel pyrrolidone derivatives for use as metap-2 inhibitors
04/29/2010US20100105705 Purinyl derivatives and their use as potassium channel modulators
04/29/2010US20100105030 Nucleic acid base pairs
04/28/2010CN1556808B Cosmetic comprising heterocyclic compound based on N6-substituted adenine,
04/27/2010US7705026 Biaryl heterocyclic compounds and methods of making and using the same
04/27/2010CA2422378C Pyrazole compounds useful as protein kinase inhibitors
04/22/2010WO2010044401A1 Morpholinopurine derivative
04/22/2010US20100099870 Novel adenine compound
04/22/2010US20100099690 Xanthine derivatives as selective hm74a agonists
04/22/2010US20100099567 Growth regulators for gramineous weeds
04/22/2010US20100099159 Caged nucleotides and oligonucleotides and their application
04/22/2010CA2740471A1 Morpholinopurine derivatives
04/21/2010EP2175859A1 Fused heteroaryl pyridyl and phenyl benzenesulfonamides as ccr2 modulators for the treament of inflammation
04/15/2010WO2010005558A3 Pi3k isoform selective inhibitors
04/15/2010US20100093998 Novel adenine compound
04/15/2010US20100093769 Compounds
04/15/2010US20100093767 Mitotic Kinase Inhibitors
04/15/2010US20100093761 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
04/15/2010US20100093737 Nucleoside and Nucleotide Analogues with Quaternary Carbon Centers and Methods of Use
04/14/2010EP2174936A1 PNA monomer and precursor
04/14/2010EP2173350A2 Stereoselective process for preparing purine dioxolane nucleoside derivatives
04/14/2010EP2173173A2 Substituted 6-anilinopurine derivatives as inhibitors of cytokinin oxidase/dehydrogenase and preparations containing these derivatives
04/14/2010CN101693713A New crystal system of entecavir, preparation process and medicament application thereof
04/14/2010CN101693695A Pyrimidine derivatives and methods of treatment related to the use thereof
04/13/2010US7696212 1-[(phenanthridin-6-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-amino-piperidin-1-yl)-xanthine; antiarthritic agents; obesity; antidiabetic agents; osteoporosis; dipeptidylpeptidase-IV (DPP-IV) inhibitors
04/13/2010CA2432303C Pyrazole compounds useful as protein kinase inhibitors
04/13/2010CA2422377C Pyrazole compounds useful as protein kinase inhibitors
04/08/2010US20100087455 Substituted xanthine compounds
04/08/2010US20100087443 9-substituted-8-oxo-adenine compounds as toll-like receptor (tlr7) modulators
04/07/2010EP2170888A1 Purine derivatives and their use as modulators of toll-like receptor 7
04/07/2010EP2170887A2 Heterocyclic compounds as raf kinase modulators
04/07/2010EP2170840A1 An improved process for preparing purine derivative
04/07/2010EP1590340B1 Inhibitors of histone deacetylase
04/06/2010US7691860 Neuropeptide Y receptor antagonists; such as 2-(trans-4-tert-butylsulfonylaminocyclohexyl)-5-(trifluoromethyl)benzimidazole; bulimia, obesity, diabetes
04/06/2010US7691853 Pyrazole compounds useful as protein kinase inhibitors
04/06/2010CA2358505C Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules
04/01/2010WO2010036904A2 Preparation of valganciclovir and its salts
04/01/2010WO2010036213A1 3-deazaneplanocin derivatives
04/01/2010WO2010034931A1 Novel substrates of o6-alkylguanine-dna alkyltransferase and mutants thereof
04/01/2010WO2010034707A1 Substituted purinyl-pyrazol derivatives and their use as potassium channel modulators
04/01/2010WO2010034706A1 Substituted purinyl-pyrazol derivatives and their use as potassium channel modulators
04/01/2010US20100081810 C-Pyrazole A2A Receptor Agonists
04/01/2010US20100081809 Amorphous valganciclovir hydrochloride
03/2010
03/31/2010EP1758596B1 Purine derivatives as adenosine a1 receptor agonists and methods of use thereof
03/30/2010US7687625 Antidiabetic agents; obesity; controlling appetite
03/30/2010US7687514 Benzimidazole derivatives
03/30/2010US7687500 Substituted oxetanes, method of making, and method of use thereof
03/25/2010WO2010033074A1 Use of a tlr7 agonist for the treatment of cancer
03/25/2010WO2010032974A2 Improved production method for adefovir dipivoxil
03/25/2010WO2010032958A2 Stabilized solid dispersion of adefovir dipivoxil and preparation method thereof
03/25/2010US20100077511 Caffeine fraction obtained from tea leaves and a method for inducing agrobacterium tumefaciens-mediated genetic transformation in plants using said caffeine fraction
03/25/2010US20100075995 Compounds
03/25/2010US20100075935 Xanthine modulators of adenosine a1 receptor
03/25/2010US20100074845 Enhanced sensitivity carbon nanotubes as targeted photoacoustic molecular imaging agents
03/24/2010EP1636231B1 Methods for preparing 9-[4-acetoxy-3-(acetoxymethyl)but-1-yl]-2-aminopurine using a compound of 2-amino-9-(2-substituted ethyl)purines
03/24/2010CN101679435A New compounds 892
03/24/2010CN101679434A 2, 6, 9-substituted purine derivatives having anti proliferative properties
03/24/2010CN101679433A Novel adenine compound
03/24/2010CN101679432A Heteroaryl compounds, compositions thereof, and use thereof as protein kinase inhibitors
03/24/2010CN101679426A 9-(pyrazol-3-yl)-9h-purine-2-amine and 3-(pyraz0l-3-yl)-3h-imidaz0[4,5-b]pyridin-5-amine derivatives and their use for the treatment of cancer
03/24/2010CN101679412A Purinones and 1h-imidazopyridinones as PKC-theta inhibitors
03/24/2010CN101679287A nicotinic acetylcholine receptor modulators
03/18/2010US20100069383 Compounds and therapeutical use thereof
03/18/2010US20100069369 Kinase Inhibitors And Their Uses
03/18/2010US20100069319 Mercaptopurine derivatives and uses thereof
03/18/2010US20100068708 Methods for Identifying Compounds that Modulate WNT Signaling in Cancer Cells
03/17/2010EP1513814B1 Novel piperidine compound
03/17/2010CN101675050A Purines as cysteine protease inhibitors
1 ... 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 ... 120